Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Marios Georgakis: GLP-1 Receptor Agonism as a Promising Approach for cSVD
Marios Georgakis,Panagiotis Zangas, Murad Omarov/DeepVascLab
Mar 9, 2026, 13:55

Marios Georgakis: GLP-1 Receptor Agonism as a Promising Approach for cSVD

Marios Georgakis, Research Group Leader and Physician at LMU Munich, Visiting Scientist at Broad Institute of MIT and Harvard University, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:

”In our new paper, we leverage human genetic data to provide support for GLP-1 receptor agonism as a promising approach for lowering the burden of cerebral small vessel disease (cSVD).

cSVD is a major unmet need in neurology with no available disease-modifying therapies.

It is a devastating and common aging-related pathology that is associated with stroke, dementia, functional decline, and mortality.

Given the strong efficacy of GLP-1 receptor agonists in reducing atherosclerotic cardiovascular disease, and the known impact of diabetes and obesity on the microvasculature, we explored if human genetic data support for their repurposing for cSVD.

Using genetic variants in the GLP1R locus that mimicked the HbA1c- or BMI-lowering effects of GLP-1 receptor agonists, we ran drug target Mendelian randomization and found associations with

  • Lower risk of lacunar (or small vessel) stroke, a clinical cSVD manifestation
  • Lower volume of white matter hyperintensities, the most widely used imaging biomarker of cSVD.

These findings provide human genetic support for evaluating GLP-1 receptor agonists in clinical trials targeting cSVD.”

Title: Genetically Simulated GLP-1 Receptor Agonism and Cerebral Small Vessel Disease

Authors: Panagiotis Zangas, Murad Omarov, Marios K. Georgakis

Read the Full Article on Neurology Genetics

Marios Georgakis: GLP-1 Receptor Agonism as a Promising Approach for cSVD

Stay updated on all scientific advances with Hemostasis Today.

cSVD Genetics GLP-1 Health Hematology Hemostasis Hemostasis News Hemostasis Today Marios Georgakis Marios K. Georgakis Medicine Murad Omarov Panagiotis Zangas small vessel disease stroke thrombosis
NewsFeed